STAT

Opinion: The cannabis boom could be good for science — and scientists

For scientists propelled by the thrill of discovery, cannabis — a commonplace yet spectacularly complex plant — offers the chance to set a new course in human understanding and health.
Source: FABRICE COFFRINI/AFP via Getty Images

I’ve been a chemistry professor for 15 years and a chemist for longer than that. Through most of that time, I paid little heed to cannabis, thinking that this plant held one main chemical of interest: tetrahydrocannabinol, its psychoactive ingredient.

I now know that cannabis contains a galaxy of unexplored compounds — cannabinoids, terpenes, flavonoids, polyphenols, and more — that may well transform our understanding of plant medicine and human biology. I find this new territory inspiring.

This discovery came about after a colleague put me in touch with a cannabis genomics company that was engaged in the

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min readCrime & Violence
STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.
STAT2 min read
STAT+: Brain Biopsies On ‘Vulnerable’ Patients At Mount Sinai Set Off Alarm Bells At FDA, Documents Show
A STAT Investigation: Brain biopsies on "vulnerable" patients at Mount Sinai set off alarm bells at FDA, documents show.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About MDMA For PTSD, A CRISPR Treatment For Blindness, And More
An FDA advisory panel will deliberate on June 4 whether to recommend approval for the first MDMA-assisted therapy for post-traumatic stress disorder.

Related Books & Audiobooks